2026-07-03 High-Risk EBC: Sharpen Your Skills in Shared Planning Education Alert Precision Oncology in HER2-Mutated NSCLC: Strategies for Today and Tomorrow 1.25 CME / ABIM MOC Are you up to date on the evolving treatment landscape for HER2-mutated NSCLC? Do you know the role of novel targeted therapies? Learn More 94.51% of Pharmacists like you who have participated in similar programs believed the program would impact patient outcomes. 回上一頁
